| Dr Peter C Fisher, MD | |
|
4252 Highland Dr, #200, Slc, UT 84124-2670 | |
| (801) 993-1800 | |
| (801) 993-1699 |
| Full Name | Dr Peter C Fisher |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 23 Years |
| Location | 4252 Highland Dr, Slc, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902847940 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 60296291205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mark's Hospital | Salt lake city, UT | Hospital |
| Alta View Hospital | Sandy, UT | Hospital |
| Lone Peak Hospital | Draper, UT | Hospital |
| University Of Utah Hospitals And Clinics | Salt lake city, UT | Hospital |
| Riverton Hospital | Riverton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Granger Medical Clinic Pc | 3476465691 | 115 |
| Granger Medical Specialists Llc | 4587074356 | 157 |
News Archive
Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has successfully completed its first robotic coronary angioplasties with R-One in Germany.
Researchers at Hospital for Special Surgery have uncovered a potential genetic trigger of systemic autoimmune disease.
Nursing homes that used a multicomponent intervention that included staff training and supportive materials for staff, residents and relatives had a lower rate of use of physical restraints such as bilateral bed rails and belts, according to a study in the May 23/30 issue of JAMA.
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies, today announced that it has been awarded a grant for $3 million from the National Institute on Drug Abuse (NIDA), an institute within the U.S. National Institutes of Health. The grant is aimed at advancing the development of an enhanced therapeutic nicotine vaccine for the treatment of smoking cessation and relapse prevention.
› Verified 1 days ago
| Entity Name | Granger Medical Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184657041 PECOS PAC ID: 3476465691 Enrollment ID: O20031105000159 |
News Archive
Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has successfully completed its first robotic coronary angioplasties with R-One in Germany.
Researchers at Hospital for Special Surgery have uncovered a potential genetic trigger of systemic autoimmune disease.
Nursing homes that used a multicomponent intervention that included staff training and supportive materials for staff, residents and relatives had a lower rate of use of physical restraints such as bilateral bed rails and belts, according to a study in the May 23/30 issue of JAMA.
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies, today announced that it has been awarded a grant for $3 million from the National Institute on Drug Abuse (NIDA), an institute within the U.S. National Institutes of Health. The grant is aimed at advancing the development of an enhanced therapeutic nicotine vaccine for the treatment of smoking cessation and relapse prevention.
› Verified 1 days ago
| Entity Name | Granger Medical Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376159368 PECOS PAC ID: 4587074356 Enrollment ID: O20201105002207 |
News Archive
Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has successfully completed its first robotic coronary angioplasties with R-One in Germany.
Researchers at Hospital for Special Surgery have uncovered a potential genetic trigger of systemic autoimmune disease.
Nursing homes that used a multicomponent intervention that included staff training and supportive materials for staff, residents and relatives had a lower rate of use of physical restraints such as bilateral bed rails and belts, according to a study in the May 23/30 issue of JAMA.
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies, today announced that it has been awarded a grant for $3 million from the National Institute on Drug Abuse (NIDA), an institute within the U.S. National Institutes of Health. The grant is aimed at advancing the development of an enhanced therapeutic nicotine vaccine for the treatment of smoking cessation and relapse prevention.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter C Fisher, MD 4252 Highland Dr, #200, Slc, UT 84124-2670 Ph: (801) 993-1800 | Dr Peter C Fisher, MD 4252 Highland Dr, #200, Slc, UT 84124-2670 Ph: (801) 993-1800 |
News Archive
Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has successfully completed its first robotic coronary angioplasties with R-One in Germany.
Researchers at Hospital for Special Surgery have uncovered a potential genetic trigger of systemic autoimmune disease.
Nursing homes that used a multicomponent intervention that included staff training and supportive materials for staff, residents and relatives had a lower rate of use of physical restraints such as bilateral bed rails and belts, according to a study in the May 23/30 issue of JAMA.
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies, today announced that it has been awarded a grant for $3 million from the National Institute on Drug Abuse (NIDA), an institute within the U.S. National Institutes of Health. The grant is aimed at advancing the development of an enhanced therapeutic nicotine vaccine for the treatment of smoking cessation and relapse prevention.
› Verified 1 days ago
Charles W Sorenson, MD Urology Medicare: Medicare Enrolled Practice Location: 324 10th Ave Ste 178, Slc, UT 84103 Phone: 801-408-2500 Fax: 801-408-1410 | |
Dr. Scott A. Hopkins, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4252 Highland Dr., #200, Slc, UT 84124 Phone: 801-993-1800 Fax: 801-993-1699 | |
Dr. Steven N. Gange, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4252 Highland Dr, #200, Slc, UT 84124 Phone: 801-993-1800 Fax: 801-993-1699 | |
Dr. Lane C. Childs, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4252 Highland Dr, #200, Slc, UT 84124 Phone: 801-993-1800 Fax: 801-993-1699 |